Muscle Wasting In Cirrhosis: Understanding The Complex Connection

why muscle wasting in cirrhosis

Muscle wasting, or sarcopenia, is a common feature of chronic liver disease, affecting around 40% of patients with cirrhosis. It is characterised by a progressive and generalised loss of muscle mass and function. The primary cause of muscle depletion is ageing, but the presence of significant liver fibrosis and reduced caloric and protein intake are also contributing factors. Patients with cirrhosis often have multiple micronutrient deficiencies, including zinc, which is critical for metabolic function. The loss of muscle mass is associated with minimal hepatic encephalopathy (MHE), a neuropsychiatric abnormality that can reduce quality of life and prognosis for patients. As such, muscle wasting has a detrimental impact on the survival of patients with cirrhosis.

Characteristics Values
Definition Muscle wasting is defined as the progressive and generalized loss of muscle mass.
Prevalence Muscle depletion is found in approximately 40% of patients with cirrhosis.
Causes Reduced nutrient intake, dietary restrictions, decreased taste sensation, decreased appetite, nausea, malnutrition, increased catabolism, limited physical activity, micronutrient deficiencies, liver fibrosis, and reduced caloric and protein intake.
Diagnosis Cross-sectional analytic morphometry using computed tomography (CT) scan or magnetic resonance imaging are considered the gold standards for research. However, for routine clinical practice, an alternative cost-effective and accurate tool is needed.
Impact Muscle wasting has a detrimental impact on the survival of patients with cirrhosis. It is associated with longer intensive care unit (ICU) stays, longer periods of mechanical ventilation, and lower overall survival following liver transplantation.
Treatment Nutritional interventions and exercise may help improve muscle wasting and survival. Supplementing with zinc can be helpful in many types of cirrhosis.

cyvigor

Malnutrition, increased catabolism, and limited physical activity are associated with cirrhosis

Cirrhosis is a systemic disease, and malnutrition is a key feature and complication. Malnutrition is prevalent in cirrhosis patients, with a reported occurrence in 5–92% of patients, depending on the screening methods and patient populations studied. Malnutrition is associated with a host of poor outcomes, including worse outcomes, and its presence carries important prognostic implications. Malnutrition is a potentially reversible prognostic marker, but it remains a challenging problem with little evidence to guide intervention.

Malnutrition in cirrhosis patients can be caused by anorexia and liver decompensation symptoms, which lead to poor dietary intake. This is further exacerbated by metabolic changes, including elevated energy expenditure, reduced glycogen storage, an accelerated starvation response, and protein catabolism, resulting in muscle and fat wasting. Malabsorption is another contributing factor, as cirrhotic patients may be unable to fully absorb or utilize the food they consume due to portal hypertensive enteropathy and changes in gut microbiota.

Increased catabolism is also associated with cirrhosis. After overnight fasting, glycogen stores in cirrhotic livers are emptied, leading to a catabolic phase with muscle loss. This can be prevented by having a late-night snack, which helps improve nitrogen metabolism, increase lean body mass, and reverse anabolic resistance and sarcopenia. Eating breakfast also improves cognitive function in cirrhosis patients.

Limited physical activity is another factor associated with cirrhosis. Sarcopenia, or muscle wasting, is common in patients with advanced cirrhosis, and reduced physical activity can be both a cause and a result. Patients with cirrhosis should be encouraged to engage in physical activity, as it can help improve their condition.

cyvigor

Micronutrient deficiencies, particularly zinc, are common in cirrhotic patients

Micronutrient deficiencies are common in patients with cirrhosis, with one of the most common deficiencies being zinc. This is due to a combination of poor intake, decreased absorption, and increased loss of zinc in urine. Zinc is critical for the function of zinc finger transcription factors, and its deficiency can lead to metabolic abnormalities. Therefore, zinc supplementation is often recommended for cirrhotic patients.

Other micronutrient deficiencies observed in cirrhotic patients include vitamin D, vitamin A, vitamin B6, and magnesium. These deficiencies are attributed to hepatic dysfunction, low dietary intake, malabsorption, maldigestion, and increased catabolism. The prevalence of malnutrition and micronutrient deficiencies in cirrhosis patients varies depending on disease severity, ranging from 20% in compensated disease to up to 80% in severe liver failure.

The loss of muscle mass, or sarcopenia, is a significant complication of cirrhosis and is associated with malnutrition, reduced caloric and protein intake, increased catabolism, and limited physical activity. Overnight fasting is discouraged for cirrhotic patients as it can worsen muscle depletion. Instead, a late-night snack is recommended to prevent the development of a catabolic phase with muscle loss.

The assessment of nutritional status in cirrhotic patients is challenging due to the alteration of standard tests by liver disease. For example, visceral proteins used to assess nutritional status, such as albumin and retinol-binding protein, are produced in the liver and may be affected by cirrhosis. The Subjective Global Assessment, which considers a patient's medical history and physical examination, may be a more suitable tool for evaluating nutritional status in this population.

Maintaining adequate protein intake is crucial for cirrhotic patients to prevent muscle wasting. However, it is important to note that a low-protein diet is not recommended for these patients, as it may contribute to hepatic encephalopathy. Instead, guidelines suggest a daily protein intake of 1.0-1.5 g/kg of dry body weight.

cyvigor

Dietary restrictions to prevent fluid accumulation can lead to reduced nutrient intake

Cirrhosis is a serious health issue that causes irreversible scarring of the liver. It is associated with several complications, including skeletal muscle atrophy or sarcopenia, which can adversely affect patient outcomes. This muscle wasting is linked to liver fibrosis and elevated levels of circulating TNFα.

Dietary restrictions are often recommended for people with cirrhosis to prevent or manage fluid accumulation, known as ascites or edema. These restrictions primarily involve limiting sodium (salt) intake, as sodium can worsen fluid retention and ascites. A low-sodium diet typically includes fresh produce, lean meats, and low-fat dairy products. However, adhering to these dietary restrictions can inadvertently lead to reduced nutrient intake.

Firstly, cirrhosis patients are already at risk of malnutrition due to poor nutritional intake, impaired absorption, and increased losses. Alcoholic cirrhosis patients, in particular, tend to consume excessive alcohol calories without adequate nutrients. Restricting dietary choices further to manage fluid accumulation can exacerbate this problem.

Secondly, cirrhosis patients often have multiple micronutrient deficiencies, especially of zinc, which is critical for metabolic functions. Poor intake, decreased absorption, and urinary losses contribute to these deficiencies. While a low-sodium diet is important for fluid management, it may inadvertently limit the variety of foods consumed, thereby reducing overall nutrient intake.

Additionally, cirrhosis can increase protein requirements, and a common misconception is that a low-protein diet should be recommended to prevent hepatic encephalopathy. However, adequate protein intake is crucial for cirrhosis patients to prevent muscle wasting and maintain muscle mass.

Therefore, it is essential for cirrhosis patients to work with healthcare professionals to ensure they receive adequate nutrition while managing fluid accumulation. This may include dietary changes, supplements, and guidance on meal timing to achieve sufficient calorie and nutrient intake throughout the day.

cyvigor

Cirrhosis is a critical health problem associated with several complications, including skeletal muscle atrophy, which adversely affects patients' clinical outcomes. While the precise mechanism underlying cirrhosis-induced muscle atrophy is not yet fully understood, studies have shown that serum factor induced by liver fibrosis leads to skeletal muscle atrophy.

One of the factors contributing to muscle wasting in cirrhosis is intestinal absorption issues. Intestinal absorption issues can be caused by maldigestion, bacterial overgrowth, or drug-related diarrhea. These issues can lead to the body's inability to absorb essential nutrients, resulting in muscle wasting.

Maldigestion can be caused by damage to the mucous lining of the small intestine, where most nutrient absorption occurs. This damage can be a result of inflammatory bowel diseases such as ulcerative colitis and Crohn's disease, autoimmune diseases such as celiac disease, or radiation therapy and chemotherapy. When the mucous lining is compromised, the body's ability to secrete digestive enzymes and absorb nutrients is affected, leading to maldigestion.

Bacterial overgrowth, specifically small intestinal bacterial overgrowth (SIBO), can also contribute to intestinal absorption issues. SIBO occurs when there is an abnormal increase in the overall bacterial population in the small intestine, particularly types of bacteria that are not commonly found in that part of the digestive tract. This overgrowth can break down bile salts, which are necessary for fat digestion, resulting in incomplete fat absorption. As a result, the absorption of fat-soluble vitamins A, D, E, and K is also compromised. In addition, bacterial overgrowth can harm the mucous lining of the small intestine, further impairing the absorption of carbohydrates and proteins.

Drug-related diarrhea can also lead to intestinal absorption issues. Certain drugs and medications can impact the mucous lining of the intestinal walls, affecting the secretion of digestive enzymes and the absorption of nutrients. This can result in diarrhea, which further impairs the body's ability to absorb nutrients effectively, contributing to muscle wasting.

In conclusion, intestinal absorption issues due to maldigestion, bacterial overgrowth, or drug-related diarrhea are factors that contribute to muscle wasting in cirrhosis. These issues impair the body's ability to absorb essential nutrients, leading to malnutrition and muscle atrophy. Understanding these intestinal absorption issues is crucial for developing therapeutic strategies to address muscle wasting in patients with cirrhosis.

cyvigor

Anabolic resistance in cirrhosis may hinder the effectiveness of exercise interventions

Cirrhosis is a state of anabolic resistance, which means that the condition can impair the beneficial responses to exercise. Anabolic resistance in cirrhosis may hinder the effectiveness of exercise interventions.

Exercise is a physiological anabolic stimulus that can reverse dysregulated protein homeostasis and potentially increase muscle mass and contractile function in healthy subjects. However, in patients with cirrhosis, there are limited studies evaluating the response to exercise. Cirrhosis is associated with hyperammonemia, which causes signaling perturbations, mitochondrial dysfunction, decreased ATP content, modifications of contractile proteins, and impaired ribosomal function. These factors contribute to anabolic resistance and may impair the beneficial responses to exercise.

In healthy individuals, endurance exercise initiates metabolic, molecular, and cellular responses that increase glucose uptake, induce a fiber-type switch, and promote mitochondrial biogenesis. Resistance exercise consistently activates mTORC1 and ribosomal biogenesis, leading to increased myofibrillar protein synthesis and muscle mass. However, it is unknown if these responses occur in patients with cirrhosis.

Nutritional supplements enhance the benefits of exercise in healthy individuals, but their impact on cirrhotic patients remains unexplored. While endurance exercise is clinically tolerated in well-compensated cirrhosis, the data on the safety of resistance exercise is conflicting. The effectiveness of exercise interventions in cirrhosis may be hindered by anabolic resistance, as the expected responses to exercise may be limited.

To optimize exercise interventions for patients with cirrhosis, further research is needed to understand the specific organ-system responses, changes in body composition, and long-term clinical outcomes associated with exercise in this population. Additionally, the role of nutritional supplements and the safety of different types of exercise regimens require further evaluation. By addressing these knowledge gaps, clinicians can develop more effective strategies to improve the health and well-being of patients with cirrhosis.

Frequently asked questions

Muscle wasting is the progressive and generalized loss of muscle mass.

Cirrhosis is a state of anabolic resistance, which can cause muscle wasting. Nutritional deficiencies, decreased absorption, and reduced physical activity are also factors that contribute to muscle wasting in cirrhotic patients.

Muscle wasting is a common feature of chronic liver disease, found in approximately 40% of patients with cirrhosis.

Muscle wasting has been found to be an independent predictor of mortality in cirrhosis. Patients with cirrhosis and muscle wasting have lower overall survival rates following liver transplantation.

Nutritional interventions and exercise are potential strategies to improve muscle wasting in cirrhosis. However, further research is needed to fully understand the underlying mechanisms and develop targeted therapies.

Written by
Reviewed by

Explore related products

Share this post
Print
Did this article help you?

Leave a comment